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Implications
Practice: The provision of autonomy-supportive 
strategies in the health care setting can sup-
port the adoption of more physically active life-
styles and improved psychological well-being 
among people living with rheumatoid arthritis, 
through promoting more autonomous reasons for 
engagement.
Policy: Policymakers who want to promote more 
active lifestyles as an avenue disease management 
should explore (i) how frontline health care pro-
fessionals can be effectively trained in approaches 
to support autonomous motivation for physical 
activity or (ii) consider how specialized physical 
activity behavior change professionals can be in-
tegrated into health care pathways.
Research: Future research should confirm the 
potential value of autonomy-supportive inter-
actions as a strategy to promote physical activity 
and improve psychological well-being among 
other clinical populations.
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Abstract
Physical inactivity is prevalent in rheumatoid arthritis (RA) 
patients, increasing the risk of poor physical health and 
compromised well-being. Interventions are therefore required 
to support physical activity (PA) behavior change in this 
population. This study examined whether a self-determination 
theory (SDT) based exercise intervention for people with RA, 
increased autonomous motivation for PA and in turn, 
moderate-to-vigorous PA (MVPA) and subjective vitality RA 
patients (n = 115) were randomized to a 3-month SDT-based 
psychological intervention + RA-tailored exercise program 
(experimental group, n = 59) or a RA-tailored exercise program 
only (control group, n = 56). During the program, the SDT-
based intervention group received one-on-one consultations 
with a PA advisor trained in delivering strategies to promote 
autonomous motivation for PA. Well-established questionnaires 
assessed autonomous and controlled motivation for PA, 
MVPA (min/week), and subjective vitality at baseline (T1) 
and 3 months (T2). Path analysis examined the hypothesized 
theoretical process model. The model demonstrated an 
excellent fit to the data (n = 70, χ2 (26) = 28.69, p = .33, 
comparative fit index = 0.99, root square mean error of 
approximation = 0.04). The intervention corresponded to 
higher autonomous motivation and lower controlled motivation 
for PA at T2, after controlling for T1 autonomous and controlled 
motivation. In turn, changes in autonomous motivation from T1 
to T2 significantly positively predicted changes in MVPA and 
subjective vitality. Results suggest an SDT based psychological 
intervention comprising autonomy-supportive strategies for 
PA predicted greater reported autonomous reasons for PA 
in RA patients participating in a tailored 3-month exercise 
program. Increased autonomous motivation linked to increased 
engagement in MVPA and feelings of vitality in these patients.
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Rheumatoid arthritis (RA) is an autoimmune disease 
affecting approximately 0.2%–1% of the adult popu-
lation worldwide [1, 2]. In RA, persistent synovial 
inflammation manifests as joint pain and swelling, 
leading to musculoskeletal deterioration and dis-
ability. In addition, chronic high-grade systemic 
inflammation incites other extra-articular disease 
manifestations, such as cardiovascular disease 
(CVD). The health burden of RA also means 
people living with this chronic disease are at signifi-
cantly increased risk of compromised psychological 
well-being [3].
Physical activity (PA) is recommended for the 
management of RA outcomes [4]. Both prospective 
and experimental studies indicate higher levels of 
PA engagement to lead to improvements in inflam-
matory disease activity, physical function, CVD risk, 
and psychological health [4–7]. However, research 
suggests that people living with RA participate in 
very low levels of PA, especially at the intensity re-
quired to accrue health benefits—that is, moderate-
to-vigorous PA (MVPA; ≥3 metabolic equivalents) 
[8, 9]. Common barriers to PA reported by RA pa-
tients are pain, fatigue, and fear of causing further 
joint damage [10], despite conclusive evidence that 
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PA is safe in this population [11]. With this in mind, 
there is a great requirement for behavioral interven-
tions that can better support people living with RA 
to participate in MVPA, in order to improve their 
physical and mental health.
For interventions to be effective, it is essential they 
target factors (i.e., determinants) that influence PA 
behavior [12, 13]. Psychological theories provide sys-
tematic frameworks to identify potential determin-
ants and to also evaluate the cognitive and affective 
mechanisms through which these determinants may 
act to encourage behavioral change [13]. In this re-
gard, self-determination theory (SDT) [14, 15] has 
been successfully applied to health behavior change 
interventions—including those targeting PA [16–18].
A fundamental concept of SDT is the assumption 
that the social environment is central to an individual’s 
quality of motivation to engage in a behavior [14]. 
Specifically, SDT proposes that social environments 
that support autonomy in regards to the target be-
havior (e.g., provide choices and options) will foster 
more autonomous motivation toward engagement 
[14, 19]. Autonomous motivation reflects intrinsic 
(e.g., fun, enjoyment) and/or personally identified 
reasons (e.g., perceived health benefits) for behav-
ioral engagement and is often associated with adap-
tive cognitive, affective, and behavioral outcomes 
[19]. In contrast, more controlling environments 
undermine autonomous motivation, leading to con-
trolled motivation whereby more introjected and ex-
ternal reasons guide engagement in a behavior (e.g., 
avoidance of shame and guilt, pressure from others). 
As a result, maladaptive cognitive, affective, and be-
havioral outcomes are likely to occur [14].
SDT advocates enhanced autonomous motivation 
as a psychological “process of change.” That is, strat-
egies to promote autonomous motivation—such as 
the provision of autonomy—are assumed to relate to 
a subsequent positive change in targeted outcomes 
(e.g., PA, Fig. 1a) [17, 19]. In the context of PA inter-
vention, examples of autonomy-supportive strategies 
that aim to facilitate more identified reasons for PA 
engagement include discussing participants’ exer-
cise/PA history and eliciting and acknowledging pre-
vious experiences and emotions toward PA, sharing 
information regarding the benefits of PA that are 
likely to be salient to the individual, ensuring discus-
sions are tailored so they are personally meaningful 
to the individual (e.g., providing rationale), and 
encouraging reflection on the links between PA and 
personally meaningful life goals or events.
Intervention studies conducted to promote PA in 
non-RA populations have employed such strategies 
and consistently demonstrate support for the role 
of autonomy support and ensuing autonomous mo-
tivation, as key psychological processes underlying 
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Fig 1 | The SDT process model for health behavior change in intervention research (a) and hypothesized model (b). Arrows (b) indicate all 
associations tested in the hypothesized model. Symbols indicate the direction of the associations.
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positive PA behavior change [17, 18]. For example, 
a randomized controlled trial (RCT) demonstrated 
that primary care patients receiving an autonomy-
supportive brief consultation from their General 
Practitioner, followed by 3-month SDT-based coun-
seling from an exercise counselor, exhibited greater 
autonomous motivation and self-reported PA 
3 months after the intervention [20]. Analysis of the 
psychological “processes of change” also revealed 
that mid-program levels of autonomous motivation 
toward PA mediated the increases in PA levels ob-
served at the end of the program. Similarly, an SDT-
based weight management program for women, in 
which health care providers were trained to deliver 
autonomy-supportive weight-loss sessions (focused 
promoting a healthy diet and PA), demonstrated in-
creased autonomous motivation toward PA following 
the intervention [21]. In turn, enhanced autonomous 
motivation was found to encourage higher PA in the 
intervention group, supporting the change mechan-
isms hypothesized by SDT (Fig.  1a). However, for 
people with RA, the role of interventions centered 
on the delivery of autonomy-supportive strategies 
(e.g., within the health care setting) to promote au-
tonomous motivation for, and engagement in, PA has 
not been examined.
In addition to the potential implications for PA, 
extant observational research has highlighted other 
positive concomitants of autonomous motivation, 
including psychological well-being [22]. For ex-
ample, studies have revealed autonomy-supportive 
strategies and resulting autonomous motivation to-
ward PA to associate with reduced prevalence of de-
pressive symptoms and improved subjective vitality 
in people with RA [23], patients on exercise referral 
[24], and physically inactive adults [25].
Subjective vitality (e.g., feeling alive, full of en-
ergy and spirit) indicates the extent to which an 
individual is experiencing eudaimonic well-being, a 
positive indicator of optimal functioning and psy-
chological health [26, 27]. Subjective vitality is con-
sidered to stem from an internal locus of causality, 
which is influenced by both physical and psycho-
logical factors [28]. For example, in the context of 
RA, an individual’s rheumatic pain (physical factor) 
may interfere with feelings of energy, but their de-
gree of subjective vitality will influence their per-
ception and perceived ability to cope with such 
adverse experiences. That is, a higher strength of 
vitality may act as a buffer to the physical challenges 
resulting from RA, representing energy that can be 
harnessed or regulated for purposive actions [26, 
28]. Subjective vitality may therefore be an indi-
cator of overall psychological functioning in people 
living with rheumatic disease. Indeed, a recent study 
in RA demonstrated significant positive associations 
between subjective vitality with quality of life and 
significant negative associations with fatigue, anx-
iety, and depression [26].
In summary, there are convincing theoretical and 
empirical reasons for employing SDT as a theoret-
ical framework on which to develop and evaluate a 
PA intervention to be applied within the RA health 
care setting. Indeed, current evidence suggests that 
interventions targeting autonomous motivation for 
PA as a psychological “process of change” may have 
the potential for encouraging PA and improving 
psychological well-being in this patient group. In 
response, we developed a 3-month SDT-based exer-
cise intervention for people living with RA, with the 
aim of promoting autonomous motivation for PA 
and, in turn, encouraging the adoption of MVPA 
and improving related psychological well-being. The 
SDT-based intervention was tested via an RCT, the 
protocol of which is detailed elsewhere [29]. Here, 
we test an SDT-based theoretical process model of 
change to examine the effects of the intervention on 
the targeted psychological process of change (i.e., 
autonomous motivation for PA) and related out-
comes. Specifically, we tested a model to examine 
whether autonomy-supportive interactions with an 
SDT-trained behavior change counselor would posi-
tively predict changes in autonomous motivation 
toward PA and, in turn, encourage higher MVPA 
and increased subjective vitality, at the end of the 
3-month exercise program (Fig. 1b).
METHODS
Patients diagnosed with RA [30] were recruited 
from Rheumatology outpatient clinics at Russells 
Hall Hospital (Dudley, UK), between March 2010 
and April 2014 (ISRCTN04121489). Exclusion 
criteria were recent joint surgery (preceding 
6  months), fibromyalgia, and co-morbidity incom-
patible with exercise as per American College of 
Sports Medicine guidelines. Eligible participants 
provided informed consent and were randomized to 
the experimental or control group (stratified based 
on gender, by a third party [Cancer Clinical Trials 
Unit, University of Birmingham]). All randomized 
participants (both experimental and control) were 
invited to participate in a 3-month exercise program 
in a local gym, tailored for people living with RA. 
Participants in the experimental group also received 
an SDT-based psychological intervention to support 
autonomous motivation for engagement in PA [29].
Exercise program (all participants)
The content of the exercise sessions was individu-
alized and based on participants’ pre-intervention 
cardio-respiratory fitness (CRF) and physical abil-
ities [7]. Full details of the exercise program are de-
scribed elsewhere [7, 29]. In brief, participants were 
advised to complete 3 × 30  min exercise sessions 
per week (two in the gym + one at home, both at 
60%–70% Heart Rate max). Participants completed 
at least one induction session in the gym until they 
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felt confident to conduct exercises independently. 
Thereafter, participants exercised in the gym with 
instructors available to answer questions. To avoid 
treatment contamination, the experimental and con-
trol groups completed their programs in different 
gyms, with comparable facilities. Instructors at both 
gyms received training regarding exercise in RA, to 
ensure the exercise program was tailored for, and 
delivered in a manner sensitive to patient’s needs.
SDT-based psychological intervention (experimental 
group only)
For patients randomized to the experimental group, 
the individualized and RA-tailored 3-month exercise 
program was supplemented by a psychological inter-
vention grounded in SDT. Participants in the experi-
mental group received four one-on-one consultations 
with a behavior change counselor, who was trained in 
the provision of strategies to promote more autono-
mous motivation for PA. Consultations were (i) one 
face-to-face consultation prior to initiating the exer-
cise program (baseline), (ii) two telephone consult-
ations from the behavior change counselor during 
the exercise program (1 and 2  months), and (iii) 
one face-to-face consultation upon completion of the 
program (3 months). During the initial consultation 
(baseline, 60  min duration), the behavior change 
counselor first elicited and acknowledged positive 
and negative experiences and emotions toward PA 
and sought to identify the patients’ knowledge of the 
benefits associated with PA for people living with 
RA. These discussions were geared toward benefits 
that were personally meaningful for the patients to 
foster more identified reasons for PA engagement 
(i.e., providing a meaningful rationale to promote 
autonomy). In this consultation, the behavior change 
counselor also encouraged the participant to reflect 
on the links between PA behavior and personally 
meaningful life goals or events, to support the intern-
alization of reasons for engaging in PA. Decisional 
balance (weighing perceived pros and cons of partici-
pation in PA) and patient-centered goal setting were 
also addressed to encourage the adoption of PA.
The first telephone consultation (1 month, 10 min 
duration) involved the behavior change counselor sup-
porting participants’ attempts to change their behavior 
and normalizing any failed attempts to be physically 
active. Counselors led patients in problem solving 
(identifying barriers to PA and formulating strategies/
solutions to overcome them) to enhance patients’ self-
efficacy for PA. Goals set during the initial face-to-face 
consultation were also revisited and revised by the pa-
tients in accordance with their perceived needs and 
capabilities. During the second telephone consultation 
(2 months, 10 min duration), behavior change coun-
selors continued to encourage participants’ attempts 
to be physically active and again guided the patient in 
problem solving regarding overcoming barriers and 
goal setting for the last period of the program.
At the end of the exercise program (3 months), 
patients were to receive a second face-to-face con-
sultation (30  min duration), during which discus-
sions between the behavior change counselor and 
participant centered on recognizing and reinfor-
cing: the internalization of participants’ PA partici-
pation, their feelings toward PA (through asking 
participants to verbalize these feelings), and plans 
to engage in PA in the future (including informa-
tion about local PA opportunities and provisions). 
A  detailed description of the content of the be-
havior change counselor consultations is also de-
scribed elsewhere [29].
For example, during their initial consultation, 
the behavior change counselor discussed partici-
pants’ exercise history, encouraged identification 
of personally relevant benefits associated with PA 
(i.e., providing a rationale to promote autonomy), 
and encouraged reflection on the links between 
PA and personally meaningful life goals or events 
(facilitating identified reasons for engagement). 
For this study, we include only participants who 
received at least their first consultation with the 
behavior change counselor (Fig.  2). This first con-
sultation (face-to-face) was the most extensive (i.e., 
1 hr) and was geared toward supporting the adop-
tion of PA. The content of the conversation between 
the behavior change counselor and patient in subse-
quent telephone (1 and 2 months) and face-to-face 
(3  months) consultations drew from and entailed 
recalling the points discussed in the initial exchange 
(e.g., to problem solve regarding barriers to PA par-
ticipation and re-visit PA goals set) [29].
Outcomes
All assessors were blinded to the intervention to 
which the participants were randomized. Assessments 
(full details have been previously published) [29] 
included measurement of RA characteristics (e.g., 
disease activity), physical health (e.g., blood pressure 
[BP], physical function), CRF, and questionnaires to 
assess autonomous and controlled motivation for PA, 
MVPA, and psychological well-being. In the present 
study, our focus was on responses to questionnaires 
administered at baseline (pre-randomization, T1) 
and at 3 months (end of the exercise program, T2).
Autonomous and controlled motivation for exercise 
engagement
Motivation regulations toward engagement in exer-
cise were measured using the 19-item Behavioral 
Regulation in Exercise Questionnaire (BREQ-2) 
[31]. Following the stem “I participate in exercise be-
cause….,” this questionnaire requires participants to 
respond to items reflecting intrinsic motivation (e.g., “I 
exercise because it is fun”), identified regulation (e.g., 
“I value the benefits of exercise”), introjected regula-
tion (“I feel guilty when I do not exercise”), external 
regulation (e.g., “I exercise because other people say 
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I  should”), and amotivation (e.g., “I do not see the 
point of exercising”). Participants rate their agreement 
with each statement on a five-point scale ranging from 
0 (not true for me) to 4 (very true for me). Composite 
scores were computed to reflect autonomous motiv-
ation (intrinsic motivation + identified regulation) 
and controlled motivation (introjected regulation + 
external regulation) for inclusion in the hypothesized 
model. This is in accordance with past research exam-
ining the motivational processes underlying PA be-
havior change, including in RA [18, 23].
Subjective vitality
Positive mental health was assessed using the 
Subjective Vitality Scale (SVS) [28]. Following the 
stem… “During the past 3–4 weeks, in my everyday 
life….,” participants are asked to respond to five 
statements (e.g., “I feel alive and full of spirit”) on 
a five-point scale, ranging from 1 (strongly disagree) 
to 5 (strongly agree). The SVS demonstrated high 
internal reliability in this study (α = 0.93 [T1] and 
α = 0.94 [T2]) and has recently been validated for 
use in RA populations [26].
Moderate-to-vigorous physical activity
PA was self-reported by all participants using the 
International Physical Activity Questionnaire 
(IPAQ) [32]. The IPAQ measures the level of PA 
across four domains: leisure-time PA, domestic and 
gardening (yard) activities, work-related PA, and 
transport-related PA. In each domain, the duration 
(in minutes) and frequency (days) of PA including 
moderate and vigorous PA are reported, and weekly 
minutes spent in MVPA are calculated ([minutes × 
days moderate PA] + [minutes × days vigorous PA]). 
The IPAQ has been used previously to assess PA 
among patients with RA [33] and is recommended 
for use in intervention studies focused on promoting 
PA [34].
RA disease characteristics and physical health
To characterize the sample, we report data col-
lected as part of the larger protocol, pertaining 
to participants’ RA disease duration, disease ac-
tivity, functional ability and RA medication, and 
physical health (including CRF). Details of these 
assessments are provided elsewhere [29]. In brief, 
Randomised (n = 115)
Allocated to control group 
(n = 56)
Allocated to experimental group 
(n = 59)
Underwent baseline data collection
(n = 45)
Data available for targeted 
variables at baseline
(n = 38)
Data available for targeted 
variables at baseline
(n = 40)
Listwise deletion: missing baseline data 
for targeted variables (n = 10)
Underwent baseline data collection
(n = 43)
Final sample included in main 
analysis
(n = 32)
Exclusion: did not attend/receive initial 
SDT-baseline consultation (n = 8)
Final sample included in main 
analysis
(n = 38) 
Fig 2 | Flow diagram of participants in the study.
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disease duration and current medication were 
self-reported and corroborated with the patient’s 
medical notes. RA disease activity was deter-
mined using the Disease Activity Score-28 (DAS-
28) [35] and functional ability was measured using 
the Stanford Health Assessment Questionnaire 
Disability Index [36]. BP was assessed using 
an electronic sphygmomanometer (Datascope 
Accutor). Serological CVD risk factors were meas-
ured from fasting blood samples (e.g., C-reactive 
protein, high-density lipoprotein cholesterol), and 
the QRISK2 score was used to indicate global 
10-year CVD risk [37]. CRF was assessed using a 
graded exercise tolerance test [29].
Data reduction
Of the n = 115 participants recruited, n = 27 were 
excluded prior to baseline data collection due to 
a new diagnosis of heart rate irregularities (n = 4), 
high BP (n = 8), other medical condition (n = 6), loss 
of interest (n = 16), and lack of time (n = 3). Baseline 
data were therefore collected from n  =  88 partici-
pants (experimental, n = 43; control, n = 45).
Participant exclusions
The flow of participants through the study is out-
lined in Fig. 2. In addition to aforementioned ex-
clusions, a further n = 10 participants were removed 
from analyses due to failure to complete question-
naires for targeted variables at T1 (motivation re-
gulations, MVPA, subjective vitality; experimental, 
n = 3 and control, n = 7), and n = 8 participants 
were excluded from the experimental group, who 
did not receive the initial SDT-based consultation 
(at baseline, following randomization). The final 
sample available for analysis was therefore n = 70 
(experimental, n = 32; control, n = 38). Statistical 
tests revealed participants excluded on the basis 
of missing baseline questionnaire data (n = 10) or 
SDT consultation (n = 8) were not significantly dif-
ferent to the final n = 70 participants included, in 
terms of demographics, RA disease characteristics, 
and physical health (Table 1). However, included 
participants were significantly less likely to be on 
Anti-TNF therapy (χ2 (1) = 7.46, p =  .01) and sig-
nificantly more likely to be on Disease-Modifying 
Anti-Rheumatic Drugs (χ2 (1) = 4.83, p = .03) than 
those excluded.
Intention-to-treat
Of the n = 70 included participants at T1, n = 33 
had missing data at T2 for at least one of the tar-
geted variables (i.e., missing data; motivation regu-
lations [n = 31], self-reported MVPA [n = 21], and 
subjective vitality [n = 33]). Questionnaire data were 
subsequently analyzed employing the principals of 
intention-to-treat. Specifically, single value imput-
ation was employed, with missing data at 3 months 
(T2) imputed using participants’ baseline data (T1; 
i.e., last observation carried forward).
Statistical analyses
Descriptive statistics were calculated and bivariate 
correlations computed to examine associations be-
tween targeted variables prior to multivariate path 
analyses. Conditions were coded as 0 = control and 
1 = experimental (i.e., a positive correlation between 
the condition and autonomous motivation indicates 
a change in autonomous motivation in favor of the 
intervention). Path analysis with maximum likelihood 
estimation was employed in conjunction with boot-
strapping to test the hypothesized model (Fig.  1b). 
Bootstrapping is a non-parametric, re-sampling 
procedure that does not impose the assumption of 
normality on the sampling distribution [38]. This 
approach is deemed superior to alternative tests in 
regards to Type-1 error rates and power, making it 
appropriate given the study sample size [38, 39].
Our hypothesized model stipulated direct paths 
between the condition at T1 and autonomous and 
controlled motivation at 3  months (end of the 
exercise program, T2). We also assumed direct as-
sociations between each composite motivation 
regulation at 3  months, with subjective vitality 
and MVPA at 3 months. For autonomous and con-
trolled motivation, subjective vitality and MVPA at 
3 months, a direct path is also stipulated from a vari-
able that represents its corresponding baseline score 
(e.g., T1 autonomous motivation has a direct path 
to T2 autonomous motivation). Regressing T1 vari-
ables onto T2 variables in this way ensures that the 
T2 variable in the model represents a “change score” 
(e.g., change in the measured variable from baseline 
[T1] to the end of the exercise program [T2]).
Model fit was evaluated using the chi-square 
statistic (χ2), comparative fit index (CFI), and root 
square mean error of approximation (RMSEA, 90% 
CI, and [PCLOSE]). A non-significant χ2 (p = < .05), 
a CFI  >0.90, and an RMSEA of <0.08 specify a 
good fit between the model and data [40, 41]. For 
the RMSEA, a p of close fit [PCLOSE] statistic >0.05 
also indicates a well-fitting model [42]. Where CFI 
is >0.95, and RMSEA is <0.06, the model is con-
sidered to demonstrate an excellent fit to the data 
[40]. The strength and direction of path coefficients 
were also considered in assessing the validity of the 
models. Standardized coefficients corresponding to 
0.1, 0.3, and 0.5 were interpreted as small, medium, 
and large effect sizes, respectively [43].
Indirect effects were also determined via examin-
ation of the bootstrap bias-corrected 95% confidence 
intervals. The unique variance in levels of MVPA 
and subjective vitality at the end of the intervention 
that could be explained by a change in autonomous 
motivation (from T1 to T2) was determined via 
examining R2 values.
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RESULTS
Descriptive statistics are reported in Table 1. During 
the 3-month exercise program, n = 24 (75%) partici-
pants received at least 3 (maximum 4) consultations 
with the behavior change counselor, comprising at 
least (i) their baseline consultation (face-to-face), (ii) 
1 × telephone consultation, and (iii) their exit con-
sultation (face-to-face, 3  months). Overall, n  =  29 
(91%) of participants received at the minimum, 
both their initial (baseline) and exit (3  months) 
face-to-face consultations.
Table  2 reports sample means for autonomous 
and controlled motivation, self-reported MVPA, 
and subjective vitality at baseline (T1) and 3 months 
(T2). Cross-sectional and time-lagged associations 
between targeted variables are also indicated.
Results revealed moderate levels of autono-
mous and controlled motivation at baseline for 
participants in both the experimental and control 
groups. The highest autonomous motivation and 
lowest controlled motivation were reported by par-
ticipants in the experimental group at 3  months 
(T2). Participants in both groups self-reported 
engaging in MVPA above recommended levels 
(i.e., >150  min/week) at baseline and 3  months 
and demonstrated high levels of subjective vitality 
at both time points. Time-lagged correlation ana-
lyses indicated significant positive relationships 
between baseline (T1) and corresponding 3-month 
data (T2) for all variables. In addition, autonomous 
motivation at T1 was significantly and positively 
linked to subjective vitality at T2, with the same 
positive association observed between subjective 
vitality at T1 and autonomous motivation at T2. 
Controlled motivation at T1 and T2 was not linked 
to either MVPA or subjective vitality in the time-
lagged analyses.
Path analyses
The hypothesized model demonstrated an ex-
cellent fit to the data (χ2 (26)  =  28.69, p  =  .33, 
CFI = .99, RMSEA = 0.04 [90% CI: 0.00 to 0.11, 
PCLOSE = .55], Fig. 3). Results indicated that re-
ceiving the SDT-based intervention was associated 
with higher autonomous motivation and lower 
controlled motivation at the end of the 3-month 
exercise program (T2), after controlling for base-
line (T1) values of these variables. In turn, au-
tonomous motivation at 3  months significantly 
positively predicted self-reported MVPA and sub-
jective vitality at 3 months. Analyses revealed au-
tonomous motivation at 3 months to account for 
3.1% and 2.7% of the unique variance in MVPA 
and subjective vitality, respectively. Controlled 
motivation did not significantly predict MVPA or 
subjective vitality.
(T2) imputed using participants’ baseline data (T1; 
i.e., last observation carried forward).
Statistical analyses
Descriptive statistics were calculated and bivariate 
correlations computed to examine associations be-
tween targeted variables prior to multivariate path 
analyses. Conditions were coded as 0 = control and 
1 = experimental (i.e., a positive correlation between 
the condition and autonomous motivation indicates 
a change in autonomous motivation in favor of the 
intervention). Path analysis with maximum likelihood 
estimation was employed in conjunction with boot-
strapping to test the hypothesized model (Fig.  1b). 
Bootstrapping is a non-parametric, re-sampling 
procedure that does not impose the assumption of 
normality on the sampling distribution [38]. This 
approach is deemed superior to alternative tests in 
regards to Type-1 error rates and power, making it 
appropriate given the study sample size [38, 39].
Our hypothesized model stipulated direct paths 
between the condition at T1 and autonomous and 
controlled motivation at 3  months (end of the 
exercise program, T2). We also assumed direct as-
sociations between each composite motivation 
regulation at 3  months, with subjective vitality 
and MVPA at 3 months. For autonomous and con-
trolled motivation, subjective vitality and MVPA at 
3 months, a direct path is also stipulated from a vari-
able that represents its corresponding baseline score 
(e.g., T1 autonomous motivation has a direct path 
to T2 autonomous motivation). Regressing T1 vari-
ables onto T2 variables in this way ensures that the 
T2 variable in the model represents a “change score” 
(e.g., change in the measured variable from baseline 
[T1] to the end of the exercise program [T2]).
Model fit was evaluated using the chi-square 
statistic (χ2), comparative fit index (CFI), and root 
square mean error of approximation (RMSEA, 90% 
CI, and [PCLOSE]). A non-significant χ2 (p = < .05), 
a CFI  >0.90, and an RMSEA of <0.08 specify a 
good fit between the model and data [40, 41]. For 
the RMSEA, a p of close fit [PCLOSE] statistic >0.05 
also indicates a well-fitting model [42]. Where CFI 
is >0.95, and RMSEA is <0.06, the model is con-
sidered to demonstrate an excellent fit to the data 
[40]. The strength and direction of path coefficients 
were also considered in assessing the validity of the 
models. Standardized coefficients corresponding to 
0.1, 0.3, and 0.5 were interpreted as small, medium, 
and large effect sizes, respectively [43].
Indirect effects were also determined via examin-
ation of the bootstrap bias-corrected 95% confidence 
intervals. The unique variance in levels of MVPA 
and subjective vitality at the end of the intervention 
that could be explained by a change in autonomous 
motivation (from T1 to T2) was determined via 
examining R2 values.
Table 1 | Participant characteristics; demographics, RA medication, disease characteristics, and physical health
Outcome measure
Total sample (n = 70) Control group (n = 38) Experimental group (n = 32)
M ± SD Range (min–max) M ± SD M ± SD
Demographics
 Age (years) 56.4 ± 12.3 24–80 55.5 ± 12.3 57.5 ±11.5
 Female sex (n) 46 (66%)  27 (71%) 19 (59%)
 Married/living with partner (n) 58 (83%)  31 (82%) 27 (84%)
RA medication
 DMARDs (n) 64 (91%)  34 (90%) 30 (94%)
 Anti-TNF (n) 6 (9%)  2 (5%) 4 (13%)
 NSAIDs (n) 21 (30%)  11 (29%) 10 (31%)
 Corticosteroids 13 (19%)  8 (21%) 5 (16%)
Disease characteristics
 Disease duration (years) 7.8 ± 9.3 1–44 8.1 ± 10.0 7.5 ± 8.7
 Disease activity (DAS-28) 3.0 ± 1.3 0.6–5.9 3.1 ± 1.3 2.8 ±1.5
 CRP (mg/L) 7.9 ± 9.3 0.2–39.0 8.9 ± 9.6 6.8 ± 9.0
 ESR (mmhr) 16.5 ±16.6 1.0–77.0 18.0 ± 17.8 14.8 ± 15.2
 Functional ability (HAQ-DI) 1.8 ± 0.6 1.0–3.0 1.7 ± 0.6 1.8 ± 0.6
Physical health (cardiovascular risk)
 Body mass index (kg/m2) 27.7 ± 4.9 19.4–42.0 27.5 ± 4.4 28.0 ± 5.5
 Systolic blood pressure 136 ± 17 99–181 134 ± 17 139 ± 16
 Diastolic blood pressure 82 ± 10 65–106 81 ± 10 83 ± 10
 Cardiovascular risk score (QRISK2) 15.3 ±12.7 0.2–45.3 14.9 ± 13.8 15.8 ± 11.7
 VO2 max (mL/min/kg) 20.6 ± 5.0 11.2–34.1 20.0 ± 5.1 21.4 ± 4.8
Included (n = 70) vs. excluded participants (n = 88) were not significantly different, in terms of age (t = 2.25, p = .64), gender, (χ2 (1) = 0.01, p = .94), disease duration 
(t = −0.15, p = .98), disease activity (DAS-28, t = −0.09, p = .13; CRP, t = 0.62, p = .56), functional ability (HAQ-DI, t = 0.96, p = .74), cardiorespiratory fitness (VO2 max, 
t = −0.79, p = .99), and overall cardiovascular risk (QRISK2, t = 1.14, p = .11), treatment with corticosteroids (χ2 (1) = 1.18, p = .18) and use of NSAIDS (χ2 (1) = 0.08, 
p = .78).
DMARD Disease Modifying Anti-Rheumatic Drug; NSAID Non-Steroidal Anti-Inflammatory Drugs; HAQ-DI Health Assessment Questionnaire-Disability Index.
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Indirect effects
Results demonstrated the intervention to have a 
significant indirect effect on subjective vitality 
(β  =  0.08 [95% CI: 0.02 to 0.20]) at 3  months, 
via promoting more autonomous motivation to-
ward PA, but not on MVPA (β  =  0.04 [95% CI: 
−0.02 to 0.12]). No significant indirect effects were 
observed on MVPA and vitality via controlled 
motivation.
DISCUSSION
The value of developing, delivering, and evaluating 
theory-based interventions to promote health be-
havior change is consistently underlined [13, 44]. 
The application of psychological theory—in this case, 
SDT—permits identification of intervention strat-
egies to target determinants of the behavior (e.g., 
autonomy support) and specifies the hypothesized 
mechanisms or processes by which an intervention 
impacts intervention outcomes (e.g., autonomous 
motivation). In this study, we tested a theory-based 
process model of change to examine the effects of 
an SDT-based intervention on targeted psycho-
logical processes (i.e., autonomous motivation for 
PA) and related outcomes in RA. Results revealed 
autonomy-supportive PA counseling sessions (pro-
vided by a behavior change counselor) delivered in 
conjunction with an individually tailored RA exer-
cise program to have a significant positive effect on 
participants’ autonomous motivation for PA. This 
positive change in autonomous motivation, in turn, 
significantly predicted higher levels of MVPA and 
improved feelings of subjective vitality. As such, re-
sults suggest a change in autonomous motivation is 
the psychological mechanism (“process of change”) 
underlying the positive changes in MVPA and sub-
jective vitality observed among RA patients in this 
intervention.
To date, several existing interventions have been 
developed and tested, with the aim of supporting PA 
behavior change in RA. It should be noted, however, 
that these interventions have largely not specified a 
theoretical basis [45] or have only loosely referred 
to a theoretical framework in outlining the design 
and evaluation of their intervention. Overall, these 
interventions have demonstrated variable success in 
promoting PA, but due to their lack of theoretical-
underpinning, it is not clear what were the psycho-
logical mechanisms that may have accounted for 
any observed changes in PA behavior following the 
intervention. In this SDT-based intervention, we 
specified autonomous motivation for PA as the de-
terminant (a psychological mechanism) targeted by 
the intervention. In testing the theoretical process 
model (Fig.  1b), we demonstrated that autonomy-
supportive interactions promoted more autonomous 
motivation for PA and, in turn, encouraged higher 
levels of engagement in MVPA and more optimal 
psychological functioning among RA patients.Ta
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Present results hold implications for the manner 
in which discussions regarding PA are delivered to 
people living with RA within the clinical context. 
Specifically, findings suggest that supplementing 
RA exercise programs with autonomy-supportive 
interactions may promote more autonomous 
reasons for engaging in PA and thus foster intern-
alization and positive PA behavior change. In this 
intervention, these autonomy-supportive exchanges 
may have inspired RA patients receiving the inter-
vention to experience greater volition and self-
endorsement of their actions and, consequently, 
increase their engagement in health-enhancing PA 
(i.e., MVPA). As such, results highlight (i) the po-
tential value of autonomy-supportive interactions as 
intervention strategies to promote PA in RA and (ii) 
the role of autonomous motivation as a modifiable 
determinant of PA in RA, while also demonstrating 
support for the theoretical tenets of SDT.
While there was no significant association ob-
served between changes in controlled motivation 
with changes in MVPA in this study, a small, weak 
positive relationship between these variables was re-
ported. This may be a result of the fact that study 
participants in both control and experimental arms 
were aware that they had consented to take part in an 
intervention with the aim of encouraging exercise. 
As a result, they felt some expectations both intern-
ally (introjected regulation) and externally (external 
regulation) to engage in MVPA. It is possible that 
the sample size in this study did not allow a signifi-
cant association between controlled motivation and 
MVPA to be detected. Thus, future research with 
larger samples (and greater statistical power) is re-
quired to explore the role of controlled motivation 
for engagement in PA among people living with 
RA. However, it is also important to recognize that 
while these results may provide initial evidence to 
suggest that controlled motivation may serve to en-
courage MVPA adoption among people living with 
RA, it is unlikely to foster the maintenance of PA in 
the longer term [15, 17]. Indeed, studies show that 
controlled motivation to engage in PA is not linked 
to PA maintenance in intervention studies with at 
least 6 months follow-up, and recommendations are 
therefore centered around promoting autonomous 
motivation (and minimizing controlled regulation) 
for PA engagement [18].
Ours is the first theory-based PA intervention 
to examine and demonstrate a significant effect of 
autonomy-supportive interactions on psychological 
well-being in RA, through enhancing autonomous 
motivation. Results suggested that RA patients who 
demonstrated greater internalization of their reasons 
for engaging in PA over the 3-month intervention 
(i.e., experienced enhanced autonomous motivation 
for PA) also reported improved feelings of vitality. 
It is possible that the autonomy-supportive inter-
actions with the behavior change counselor inspired 
RA patients to feel more “in control” (i.e., acting 
of their own volition) and better equipped psycho-
logically to cope with the physical challenges re-
sulting from RA, through engaging in PA [26, 28]. 
Thus, findings may suggest interventions targeting 
autonomous motivation for PA might not only to 
translate to positive changes in PA, but also to RA 
Treatment
Autonomous 
motivation T2
Controlled 
motivation T2
Moderate-to-
vigorous PA  T2
Subjective     
vitality T2
0 = Control
1 = Experimental
.36**
−.29**
Autonomous 
motivation T1
Controlled 
motivation T1
Moderate-to-
vigorous PA T1
Subjective     
vitality T1
.48**
.64**
.18*
.22**
.79**
.73**
.10
−.04
Fig 3 | Data fit to the hypothesized model. Values represent path coefficients (β). *p < .05, **p < .01.
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patients experiencing more optimal psychological 
well-being.
Similar findings to those observed herein have 
been reported where SDT-based PA interventions 
have been delivered in other health care settings (e.g., 
primary care, exercise referral) [17]. Thus, the provi-
sion of autonomy-supportive strategies—delivered by 
key health care professionals—may offer an effective 
PA intervention strategy across the broader clin-
ical context [46]. Indeed, health care professionals 
are important resources for promoting PA due to 
their potential to reach a considerable number of 
patients and their credibility from the patient per-
spective. However, the health care context presents 
unique challenges, such as constraints on time and 
resources. Consequently, it is critical that pathways 
to implementation are developed that consider these 
challenges in parallel to the delivery of PA promo-
tion programs. The World Health Organisation has 
proposed that successful PA implementation can 
be achieved with the capacity building of frontline 
health care practitioners managing the patients (e.g., 
rheumatologists) [47]. Inferring from this study, such 
capacity building would constitute conveying infor-
mation about PA and its health benefits in RA, as 
well as instruction in the delivery of intervention 
approaches to support autonomous motivation for 
PA. However, to ensure consistency and confidence 
in PA messaging, such capacity building is likely to 
require substantial training provisions for rheuma-
tology health professionals, integrated at all stages of 
their career. This will likely come at a considerable 
cost and relies on commitment from both Health 
Service systems and educational partners. Thus, an 
alternative approach to implementation may be to 
integrate specialized PA behavior change profes-
sionals into Rheumatology care pathways, with ex-
pertise in relevant behavioral theories (in this case, 
SDT), who are trained in strategies to promote au-
tonomous motivation for PA.
While significant effects were observed for key 
outcomes tested in our SDT-based process model of 
change, challenges in implementation and measure-
ment may have influenced intervention efficacy and 
fidelity. First, we were not able to administer an ob-
jective measure to evaluate the autonomy-supportive 
interactions (either face-to-face or via telephone), to 
ascertain the degree to which intervention strategies 
were delivered as specified and in accordance with 
the principles of SDT [48]. Second, while all partici-
pants received their initial face-to-face consultation 
at the commencement of the RA-tailored exercise 
program, not all participants received follow-up 
telephone calls and participated in their exit consult-
ation. This resulted in some participants receiving a 
lower “dose” of intervention than anticipated and 
may have impacted present results.
Nevertheless, positive changes in autonomous mo-
tivation for PA and MVPA were observed, where at 
least one SDT-based, face-to-face consultation was re-
ceived upon beginning the exercise program. Thus, 
at the minimum, the initial exchanges between the 
behavior change counselor and patients may have 
been sufficient to promote internalization of reasons 
for PA engagement and inspire positive PA behavior 
change. In this regard, it would be interesting for 
future intervention studies to elucidate the minim-
ally important “dose” of intervention required (both 
number and type of SDT-based exchanges) to ob-
serve positive (and clinically meaningful) changes in 
PA behavior among people with RA. This will have 
implications for facilitating the implementation of 
PA advice in this population, enabling efficiency 
in terms of time and resources. In this study, 91% 
(n = 29/32) of participants received both their ini-
tial (baseline) and exit (3 months) face-to-face con-
sultations with the behavior change counselor, and 
75% (n = 24/32) of participants received both their 
face-to-face consultations and at least one follow-up 
telephone call (at 1 or 2 months). Thus, it is likely 
that two to three SDT-based consultations may be 
required to encourage the initial adoption of PA 
among this patient group.
In interpreting the results of the current study, 
the discrepancy between the relationships observed 
in our hypothesized model versus changes in pre- 
and post-intervention levels of MVPA should also 
be acknowledged. In Table 2, minutes of MVPA de-
creased between baseline and the end of the exercise 
intervention in both the experimental and control 
groups. According to our hypothesized model, we 
would expect increased estimates of MVPA among 
participants who received the SDT-based interven-
tion. That is, the more self-determined one is (i.e., 
more autonomous motivation for PA) the higher 
their engagement in MVPA. The overall decreases 
in MVPA observed at the group level among par-
ticipants in the experimental arm can therefore 
not be explained by the relationships specified in 
the hypothesized model. The group-level decrease 
in MVPA may therefore result from other factors 
that we were not able to measure in our study (e.g., 
environmental factors such as weather) and/or 
account for in our statistical analysis (e.g., disease 
activity). In addition, it is possible that after com-
pleting the RA-tailored exercise program (which 
both groups received), the participants in both arms 
changed how they reported their MVPA (e.g., due 
to increased awareness of what constituted MVPA), 
accounting for the decrease seen in both the ex-
perimental and control groups. Further, a reliance 
on self-reported MVPA may have also affected the 
validity of MVPA estimates in this study. While we 
determined MVPA assessed via an accelerometer 
in the larger protocol [29], compliance with device 
wear at 3 months (T2) was not sufficient to permit 
evaluation of the theory-based process model using 
accelerometer-assessed MVPA. Future research 
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employing device-based assessments of PA (e.g., ac-
celerometers) is warranted to corroborate the value 
of SDT-based interventions for promoting uptake 
(and subsequent maintenance) of MVPA among 
people living with RA.
The generalizability of current results also war-
rants further discussion. Participants recruited to 
this study represented a cohort of RA patients with 
controlled diseases activity (DAS-28  =  <3.2) and 
who were willing to undertake a lifestyle change 
in regards to their PA. Moreover, levels of self-
reported MVPA by both groups, at all time points, 
were higher than the recommended 150 min/week, 
and subjective vitality scores indicated that partici-
pants in general reported positive mental health. It 
is therefore possible that findings may not be gener-
alizable to RA patients with active disease, who are 
considered “physically inactive” (according to the 
150 min/week MVPA criteria), with more comprom-
ised psychological well-being, and/or those who are 
not yet ready to engage in behavioral change. The 
efficacy of this SDT-based exercise intervention 
should therefore be tested among a more hetero-
geneous sample of RA patients, as intervention ap-
proaches and strategies may need to be adapted to 
consider these factors. With that said, the high levels 
of MVPA observed in this study may to some extent 
represent a mismatch between the manner in which 
government recommendations for PA are framed 
(i.e., largely based on self-report of structured exer-
cise and purposeful MVPA) and the questions asked 
in the IPAQ: that is, the IPAQ assessing MVPA ac-
cumulated during all lifestyle activities, across sev-
eral life domains (e.g., occupational, domestic, and 
leisure time MVPA) [49]. As such, it is perhaps not 
surprising that levels of MVPA are reported to ex-
ceed 150 min/week in this study. Indeed, it is likely 
that levels of MVPA among the current sample 
of people with RA are lower than those reported 
herein.
It is also important to recognize that the missing 
data at T2, and the manner in which these data 
were imputed, may have impacted the results re-
ported. Single imputation was used to compute 
missing data in this study. This method does not 
account for the uncertainty of missing data and 
may result in standard errors of the estimates that 
are likely too small, potentially leading to Type-1 
error [50]. The results of this study should there-
fore be interpreted considering these limitations, as 
the precision of the results and variability in MVPA 
and subjective vitality explained by our hypothe-
sized model may have been overestimated. Still, 
even in acknowledging these limitations, the re-
sults of this study add an important contribution to 
the literature. The findings provide novel evidence 
of the potential value of SDT-based interventions 
for promoting MVPA and vitality among people 
with RA and as a result, provide an informed basis 
upon which to develop future interventional ef-
forts. Future work in this area should aim to con-
firm the value of autonomy-supportive strategies 
for encouraging MVPA and increasing feelings of 
vitality in RA.
CONCLUSIONS
This is the first RCT to investigate whether SDT-
based PA consultations delivered in conjunction 
with an RA-tailored exercise program were ef-
fective for promoting autonomous motivation for 
PA among people with RA. Overall, the results of 
the trial are in line with the motivational processes 
hypothesized by SDT. That is, results demonstrated 
that autonomy-supportive PA consultations corres-
pond to positive changes in participant’s autono-
mous motivation for PA and, subsequently, their 
engagement in (self-reported) MVPA and subjective 
vitality on the conclusion of a 3-month RA exercise 
program. As such, interventions targeting autono-
mous motivation as a key psychological determinant 
of PA behavior in RA may provide a valuable contri-
bution to encouraging PA behavior change in these 
patients. The provision of autonomy-supportive 
strategies targeting PA may offer an effective PA 
intervention strategy in this regard.
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